Sonoma Pharmaceuticals (SNOA) Competitors $2.30 -0.06 (-2.54%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.30 +0.00 (+0.17%) As of 04/17/2025 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNOA vs. LSB, SNYR, ABP, CING, MIRA, GOVX, NRSN, GLYC, IPA, and LPTXShould you be buying Sonoma Pharmaceuticals stock or one of its competitors? The main competitors of Sonoma Pharmaceuticals include Lakeshore Biopharma (LSB), Synergy CHC Corp. (Uplisting) (SNYR), Abpro (ABP), Cingulate (CING), MIRA Pharmaceuticals (MIRA), GeoVax Labs (GOVX), NeuroSense Therapeutics (NRSN), GlycoMimetics (GLYC), ImmunoPrecise Antibodies (IPA), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. Sonoma Pharmaceuticals vs. Lakeshore Biopharma Synergy CHC Corp. (Uplisting) Abpro Cingulate MIRA Pharmaceuticals GeoVax Labs NeuroSense Therapeutics GlycoMimetics ImmunoPrecise Antibodies Leap Therapeutics Lakeshore Biopharma (NASDAQ:LSB) and Sonoma Pharmaceuticals (NASDAQ:SNOA) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Does the MarketBeat Community prefer LSB or SNOA? Sonoma Pharmaceuticals received 216 more outperform votes than Lakeshore Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformLakeshore BiopharmaN/AN/ASonoma PharmaceuticalsOutperform Votes21667.50% Underperform Votes10432.50% Do institutionals & insiders believe in LSB or SNOA? 52.6% of Lakeshore Biopharma shares are held by institutional investors. Comparatively, 2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. 3.9% of Sonoma Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has preferable valuation & earnings, LSB or SNOA? Sonoma Pharmaceuticals has lower revenue, but higher earnings than Lakeshore Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLakeshore Biopharma$672.27M0.02-$61.09MN/AN/ASonoma Pharmaceuticals$13.97M0.27-$4.84M-$4.02-0.57 Which has more risk & volatility, LSB or SNOA? Lakeshore Biopharma has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, Sonoma Pharmaceuticals has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Does the media favor LSB or SNOA? In the previous week, Lakeshore Biopharma had 1 more articles in the media than Sonoma Pharmaceuticals. MarketBeat recorded 2 mentions for Lakeshore Biopharma and 1 mentions for Sonoma Pharmaceuticals. Sonoma Pharmaceuticals' average media sentiment score of 1.00 beat Lakeshore Biopharma's score of -0.50 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Lakeshore Biopharma Negative Sonoma Pharmaceuticals Positive Is LSB or SNOA more profitable? Lakeshore Biopharma has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -26.82%. Lakeshore Biopharma's return on equity of 0.00% beat Sonoma Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Lakeshore BiopharmaN/A N/A N/A Sonoma Pharmaceuticals -26.82%-68.98%-26.39% SummaryLakeshore Biopharma and Sonoma Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks. Get Sonoma Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNOA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNOA vs. The Competition Export to ExcelMetricSonoma PharmaceuticalsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.72M$4.04B$5.30B$7.34BDividend YieldN/A39.51%5.12%4.30%P/E Ratio-0.5727.6821.8617.80Price / Sales0.2747.06380.5497.74Price / CashN/A51.0838.2634.64Price / Book0.765.816.453.98Net Income-$4.84M$67.09M$3.22B$247.81M7 Day Performance0.44%2.00%2.85%1.80%1 Month Performance-29.23%-4.80%-8.67%-6.81%1 Year Performance1,368.71%14.47%11.46%1.31% Sonoma Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNOASonoma Pharmaceuticals1.2062 of 5 stars$2.30-2.5%N/A+1,268.2%$3.72M$13.97M-0.57180Short Interest ↓Positive NewsLSBLakeshore Biopharma0.5045 of 5 stars$1.76+4.1%N/AN/A$15.73M$672.27M0.00773Short Interest ↑Gap UpSNYRSynergy CHC Corp. (Uplisting)3.1191 of 5 stars$1.79+0.4%$10.00+458.7%N/A$15.34M$34.83M0.0040Lockup ExpirationNews CoverageGap DownHigh Trading VolumeABPAbproN/A$0.30+6.9%$4.00+1,255.9%N/A$15.29M$122,000.000.0015Gap UpCINGCingulate2.0878 of 5 stars$4.02+5.8%$16.00+298.0%+385.1%$15.15MN/A-0.2720Short Interest ↑Negative NewsMIRAMIRA Pharmaceuticals2.7181 of 5 stars$0.89+2.9%$14.00+1,473.0%+15.9%$14.96MN/A-1.592Short Interest ↓News CoverageGap DownGOVXGeoVax Labs2.3206 of 5 stars$1.07+4.9%$14.20+1,227.1%-43.2%$14.81M$3.95M-0.1910Analyst ForecastShort Interest ↑Analyst RevisionNRSNNeuroSense Therapeutics0.4672 of 5 stars$1.08+1.9%N/A-35.4%$14.76MN/A-1.6910Short Interest ↑GLYCGlycoMimetics1.1842 of 5 stars$0.22+10.0%N/A-90.2%$14.32M$10,000.000.0050Analyst ForecastIPAImmunoPrecise Antibodies2.7068 of 5 stars$0.46+6.0%$4.00+775.1%-65.5%$14.20M$24.00M-0.5980Short Interest ↓LPTXLeap Therapeutics1.5538 of 5 stars$0.34+5.2%$4.92+1,341.8%-87.9%$14.07MN/A-0.1840Short Interest ↑Gap Down Related Companies and Tools Related Companies Lakeshore Biopharma Competitors Synergy CHC Corp. (Uplisting) Competitors Abpro Competitors Cingulate Competitors MIRA Pharmaceuticals Competitors GeoVax Labs Competitors NeuroSense Therapeutics Competitors GlycoMimetics Competitors ImmunoPrecise Antibodies Competitors Leap Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SNOA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our Partners100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?Recently, President Trump decided to kill the coin, for good reason. It now costs 4 cents to make a single pen...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonoma Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonoma Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SNOA Stock Free SNOA Stock Alerts